BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19325139)

  • 1. Site-specific antiatherogenic effect of the antioxidant ebselen in the diabetic apolipoprotein E-deficient mouse.
    Chew P; Yuen DY; Koh P; Stefanovic N; Febbraio MA; Kola I; Cooper ME; de Haan JB
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):823-30. PubMed ID: 19325139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice.
    Lewis P; Stefanovic N; Pete J; Calkin AC; Giunti S; Thallas-Bonke V; Jandeleit-Dahm KA; Allen TJ; Kola I; Cooper ME; de Haan JB
    Circulation; 2007 Apr; 115(16):2178-87. PubMed ID: 17420349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiatherosclerotic and renoprotective effects of ebselen in the diabetic apolipoprotein E/GPx1-double knockout mouse.
    Chew P; Yuen DY; Stefanovic N; Pete J; Coughlan MT; Jandeleit-Dahm KA; Thomas MC; Rosenfeldt F; Cooper ME; de Haan JB
    Diabetes; 2010 Dec; 59(12):3198-207. PubMed ID: 20823099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxiredoxin 2 deficiency exacerbates atherosclerosis in apolipoprotein E-deficient mice.
    Park JG; Yoo JY; Jeong SJ; Choi JH; Lee MR; Lee MN; Hwa Lee J; Kim HC; Jo H; Yu DY; Kang SW; Rhee SG; Lee MH; Oh GT
    Circ Res; 2011 Sep; 109(7):739-49. PubMed ID: 21835911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the ROCK1 branch of the transforming growth factor-beta pathway contributes to RAGE-dependent acceleration of atherosclerosis in diabetic ApoE-null mice.
    Bu DX; Rai V; Shen X; Rosario R; Lu Y; D'Agati V; Yan SF; Friedman RA; Nuglozeh E; Schmidt AM
    Circ Res; 2010 Apr; 106(6):1040-51. PubMed ID: 20133903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signaling of Serum Amyloid A Through Receptor for Advanced Glycation End Products as a Possible Mechanism for Uremia-Related Atherosclerosis.
    Belmokhtar K; Robert T; Ortillon J; Braconnier A; Vuiblet V; Boulagnon-Rombi C; Diebold MD; Pietrement C; Schmidt AM; Rieu P; Touré F
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):800-9. PubMed ID: 26988587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice.
    Lu J; Xiang G; Liu M; Mei W; Xiang L; Dong J
    Atherosclerosis; 2015 Dec; 243(2):438-48. PubMed ID: 26520898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmalogen modulation attenuates atherosclerosis in ApoE- and ApoE/GPx1-deficient mice.
    Rasmiena AA; Barlow CK; Stefanovic N; Huynh K; Tan R; Sharma A; Tull D; de Haan JB; Meikle PJ
    Atherosclerosis; 2015 Dec; 243(2):598-608. PubMed ID: 26545014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The modified selenenyl amide, M-hydroxy ebselen, attenuates diabetic nephropathy and diabetes-associated atherosclerosis in ApoE/GPx1 double knockout mice.
    Tan SM; Sharma A; Yuen DY; Stefanovic N; Krippner G; Mugesh G; Chai Z; de Haan JB
    PLoS One; 2013; 8(7):e69193. PubMed ID: 23874911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial Cell-Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice.
    Chen X; Qian S; Hoggatt A; Tang H; Hacker TA; Obukhov AG; Herring PB; Seye CI
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):75-83. PubMed ID: 27856454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes.
    Wang Z; Jiang Y; Liu N; Ren L; Zhu Y; An Y; Chen D
    Atherosclerosis; 2012 Apr; 221(2):387-96. PubMed ID: 22305260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced alpha-lipoic acid synthase gene expression exacerbates atherosclerosis in diabetic apolipoprotein E-deficient mice.
    Yi X; Xu L; Hiller S; Kim HS; Maeda N
    Atherosclerosis; 2012 Jul; 223(1):137-43. PubMed ID: 22658261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactive Oxygen Species Can Provide Atheroprotection via NOX4-Dependent Inhibition of Inflammation and Vascular Remodeling.
    Gray SP; Di Marco E; Kennedy K; Chew P; Okabe J; El-Osta A; Calkin AC; Biessen EA; Touyz RM; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):295-307. PubMed ID: 26715682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ebselen treatment prevents islet apoptosis, maintains intranuclear Pdx-1 and MafA levels, and preserves β-cell mass and function in ZDF rats.
    Mahadevan J; Parazzoli S; Oseid E; Hertzel AV; Bernlohr DA; Vallerie SN; Liu CQ; Lopez M; Harmon JS; Robertson RP
    Diabetes; 2013 Oct; 62(10):3582-8. PubMed ID: 23801580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Txnip ablation reduces vascular smooth muscle cell inflammation and ameliorates atherosclerosis in apolipoprotein E knockout mice.
    Byon CH; Han T; Wu J; Hui ST
    Atherosclerosis; 2015 Aug; 241(2):313-21. PubMed ID: 26062991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt Signaling Pathway Inhibitor Sclerostin Inhibits Angiotensin II-Induced Aortic Aneurysm and Atherosclerosis.
    Krishna SM; Seto SW; Jose RJ; Li J; Morton SK; Biros E; Wang Y; Nsengiyumva V; Lindeman JH; Loots GG; Rush CM; Craig JM; Golledge J
    Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):553-566. PubMed ID: 28062506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldosterone increases early atherosclerosis and promotes plaque inflammation through a placental growth factor-dependent mechanism.
    McGraw AP; Bagley J; Chen WS; Galayda C; Nickerson H; Armani A; Caprio M; Carmeliet P; Jaffe IZ
    J Am Heart Assoc; 2013 Feb; 2(1):e000018. PubMed ID: 23525413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smooth Muscle Cell-Derived Interleukin-17C Plays an Atherogenic Role via the Recruitment of Proinflammatory Interleukin-17A+ T Cells to the Aorta.
    Butcher MJ; Waseem TC; Galkina EV
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1496-506. PubMed ID: 27365405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ticagrelor, a P2Y12 antagonist, attenuates vascular dysfunction and inhibits atherogenesis in apolipoprotein-E-deficient mice.
    Ganbaatar B; Fukuda D; Salim HM; Nishimoto S; Tanaka K; Higashikuni Y; Hirata Y; Yagi S; Soeki T; Sata M
    Atherosclerosis; 2018 Aug; 275():124-132. PubMed ID: 29902700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of glutathione peroxidase-1 deficiency on macrophage foam cell formation and proliferation: implications for atherogenesis.
    Cheng F; Torzewski M; Degreif A; Rossmann H; Canisius A; Lackner KJ
    PLoS One; 2013; 8(8):e72063. PubMed ID: 23991041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.